Patients’ and clinicians’ perceptions of the clinical utility of predictive risk models for chemotherapy-related symptom management: Qualitative exploration using focus groups and interviews. (Preprint)
Authors:
- Morven MillerMMMorven Miller
- Lisa McCannLMLisa McCann
- Liane LewisLLLiane Lewis
- Christine MiaskowskiCMChristine Miaskowski
- Emma ReamEREmma Ream
- Andrew DarleyADAndrew Darley
- Jenny HarrisJHJenny Harris
- Grigorios KotronoulasGKGrigorios Kotronoulas
- Geir V BergGBGeir V Berg
- Simone LubowitzkiSLSimone Lubowitzki
- Jo ArmesJAJo Armes
- Elizabeth PatirakiEPElizabeth Patiraki
Open Access
- 1 June 2023
- journal article
- research article
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 26, e49309
Abstract
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Interest in the application of predictive risk models (PRMs) in healthcare to identify people most likely to experience disease and treatment-related complications is increasing. In cancer care, these techniques are focused primarily on prediction of survival or life-threatening toxicities (e.g. febrile neutropenia). Fewer studies focused on use of PRMs for symptoms or supportive care needs. The application of PRMs to chemotherapy-related symptoms (CRS) would enable earlier identification and initiation of prompt, personalised and tailored interventions. While some PRMs exist for CRS, few were translated into clinical practice and human factors associated with their use were not reported. Objective: Explore patients’ and clinicians’ perspectives of the utility and real-world application of PRMs to improve the management of CRS. Methods: Focus groups (n=10) and interviews (n=5) were conducted with patients (n=28) and clinicians (n=26) across five European countries. Interactions were audio-recorded, transcribed verbatim and analysed thematically. Results: Both clinicians and patients recognized the value of having individualised risk predictions for CRS and appreciated how this type of information would facilitate the provision of tailored preventative treatments and/or supportive care interactions. However cautious and skeptical attitudes towards the use of PRMs in clinical care were noted by both groups particularly in relationship to the uncertainty regarding how the information would be generated. Visualisation and presentation of PRM information in a usable and useful format for both patients and clinicians was identified as a challenge to their successful implementation in clinical care. Conclusions: Findings from this study provide information on clinicians’ and patients’ perspectives on the clinical use of PRMs for the management of CRS. These international perspectives are important because they provide insight into the risks and benefits of using PRMs to evaluate CRS. In addition, they highlight the need to find ways to more effectively present and use this information in clinical practice. Further research that explores the best ways to incorporate this type of information while maintaining the human side of care is warranted. Clinical Trial: This paper reports on a secondary objective from a larger programme of work Trial Registration: Clinical Trials.gov NCT02356081Keywords
All Related Versions
This publication has 57 references indexed in Scilit:
- Systematic Review of the Importance of Human Factors in Incorporating Healthcare Automation2021
- Comorbid conditions and health-related quality of life in long-term cancer survivors—associations with demographic and medical characteristicsJournal of Cancer Survivorship, 2018
- Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: A systematic reviewCritical Reviews in Oncology/Hematology, 2016
- Mortality, length of stay, and health care costs of febrile neutropenia-related hospitalizations among patients with breast cancer in the United StatesSupportive Care in Cancer, 2015
- Randomised controlled trial of a tailored information pack for patients undergoing surgery and treatment for rectal cancerEuropean Journal of Oncology Nursing, 2014
- Physical and psychosocial problems in cancer survivors beyond return to work: a systematic reviewPsycho-Oncology, 2013
- Symptoms tell it all: A systematic review of the value of symptom assessment to predict survival in advanced cancer patientsCritical Reviews in Oncology/Hematology, 2012
- Immediate versus delayed self-reporting of symptoms and side effects during chemotherapy: Does timing matter?European Journal of Oncology Nursing, 2011
- Cancer patients' trust in their physician—a reviewPsycho-Oncology, 2011
- Chemotherapy outpatients’ unplanned presentations to hospital: a retrospective studySupportive Care in Cancer, 2010